Andrew von Eschenbach
Showing 1–3 of 3 transcripts.
- Milken Institute56 min
Transforming Healthcare with Technology
Andrew von Eschenbach, Michael Acton Smith OBE, Alex Beauvais, Sarah Haywood, Prasanth Manghat, Ben Maruthappu
The healthcare sector is undergoing a fundamental transformation driven by an aging global population and rising mental health concerns, shifting from acute, hospital-centric models to personalized, home-based preventative care. Digital innovations such as remote monitoring, gene editing, and consumer-facing apps promise significant cost reductions through value-based incentives, yet this progress is hindered by the digital divide among the elderly, fragmented legacy data systems, and a lack of rigorous regulation for unverified digital health products. To realize these benefits, the industry must bridge the gap between high-tech solutions and vulnerable demographics while establishing robust information governance to build public trust and ensure equitable, scalable outcomes.
- Milken Institute1h 11m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science (updated II)
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken, Mike Milken, Tom Frieden, Andy Van Eschenbach, Jack Andreyka
A comprehensive analysis of global bioscience reveals a dramatic increase in life expectancy and major breakthroughs in disease eradication, such as the near-elimination of polio and HIV management through programs like PEPFAR. Despite these successes, the sector faces a critical funding crisis where declining NIH grant success rates and inflation-adjusted budget cuts threaten the pipeline of young researchers and the translation of genetic discoveries into new treatments. Strategic initiatives like the Brain Initiative, precision medicine efforts, and the shift toward prevention are now essential to address rising chronic disease burdens and sustain the bioscience industry as a primary driver of US economic growth.
- Milken Institute1h 12m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken
The bioscience forum highlighted the sector's massive contribution to increased global life expectancy and economic growth while emphasizing that flat budgets and inflation have critically reduced NIH grant success rates to below 20%. Distinguished leaders such as Francis Collins and Tom Frieden warned that sustained funding cuts and a 90% treatment-versus-prevention spending imbalance threaten American innovation and the careers of young researchers. Despite these financial constraints, the event underscored significant breakthroughs in areas like genomic medicine and disease eradication, with panelists urging renewed investment to maintain global health leadership and drive future discoveries.